Nasal-type NK/T cell lymphoma: clinical features and treatment outcome

por Lee, J, Kim, W S, Park, Y H, Park, S H, Park, K W, Kang, J H, Lee, S S, Lee, S I, Lee, S-H, Kim, K, Jung, C W, Ahn, Y C, Ko, Y H, Park, K
Publicado 2005

Immune responses to the 105AD7 human anti-idiotypic vaccine after intensive chemotherapy, for osteosarcoma

por Pritchard-Jones, K, Spendlove, I, Wilton, C, Whelan, J, Weeden, S, Lewis, I, Hale, J, Douglas, C, Pagonis, C, Campbell, B, Alvarez, P, Halbert, G, Durrant, L G
Publicado 2005

Insulin-like growth factor binding protein-6 inhibits prostate cancer cell proliferation: implication for anticancer effect of diethylstilbestrol in hormone refractory prostate can...

por Koike, H, Ito, K, Takezawa, Y, Oyama, T, Yamanaka, H, Suzuki, K
Publicado 2005

Lack of clinical efficacy of imatinib in metastatic melanoma

por Ugurel, S, Hildenbrand, R, Zimpfer, A, La Rosée, P, Paschka, P, Sucker, A, Keikavoussi, P, Becker, J C, Rittgen, W, Hochhaus, A, Schadendorf, D
Publicado 2005

Genomic and gene expression profiling of minute alterations of chromosome arm 1p in small-cell lung carcinoma cells

por Henderson, L-J, Coe, B P, Lee, E H L, Girard, L, Gazdar, A F, Minna, J D, Lam, S, MacAulay, C, Lam, W L
Publicado 2005

Somatostatin receptors 2 and 5 are preferentially expressed in proliferating endothelium

por Adams, R L, Adams, I P, Lindow, S W, Zhong, W, Atkin, S L
Publicado 2005

Preclinical relevance of dosing time for the therapeutic index of gemcitabine–cisplatin

por Li, X M, Tanaka, K, Sun, J, Filipski, E, Kayitalire, L, Focan, C, Lévi, F
Publicado 2005

A phase II study of biweekly oxaliplatin plus infusional 5-fluorouracil and folinic acid (FOLFOX-4) as first-line treatment of advanced gastric cancer patients

por De Vita, F, Orditura, M, Matano, E, Bianco, R, Carlomagno, C, Infusino, S, Damiano, V, Simeone, E, Diadema, M R, Lieto, E, Castellano, P, Pepe, S, De Placido, S, Galizia, G, Di Martino, N, Ciardiello, F, Catalano, G, Bianco, A R
Publicado 2005

Pharmacokinetics and metabolism of ifosfamide in relation to DNA damage assessed by the COMET assay in children with cancer

por Willits, I, Price, L, Parry, A, Tilby, M J, Ford, D, Cholerton, S, Pearson, A D J, Boddy, A V
Publicado 2005

Phase III study of 5FU, etoposide and leucovorin (FELV) compared to epirubicin, cisplatin and 5FU (ECF) in previously untreated patients with advanced biliary cancer

por Rao, S, Cunningham, D, Hawkins, R E, Hill, M E, Smith, D, Daniel, F, Ross, P J, Oates, J, Norman, A R
Publicado 2005

Defects in muscarinic receptor-coupled signal transduction in isolated parotid gland cells after in vivo irradiation: evidence for a non-DNA target of radiation

por Coppes, R P, Meter, A, Latumalea, S P, Roffel, A F, Kampinga, H H
Publicado 2005

P53 abnormalities and outcomes in colorectal cancer: a systematic review

por Munro, A J, Lain, S, Lane, D P
Publicado 2005

Non-small-cell lung cancer in a French department, (1982–1997): management and outcome

por Foeglé, J, Hédelin, G, Lebitasy, M P, Purohit, A, Velten, M, Quoix, E
Publicado 2005

Expression of V(1A) and GRP receptors leads to cellular transformation and increased sensitivity to substance-P analogue-induced growth inhibition

por MacKinnon, A C, Tufail-Hanif, U, Lucas, C D, Jodrell, D, Haslett, C, Sethi, T
Publicado 2005

Effect of intraperitoneally administered recombinant murine granulocyte-macrophage colony-stimulating factor (rmGM-CSF) on the cytotoxic potential of murine peritoneal cells

por Klimp, A H, Regts, J, Scherphof, G L, de Vries, E G E, Daemen, T
Publicado 1999

Granulocyte, granulocyte–macrophage, and macrophage colony-stimulating factors can stimulate the invasive capacity of human lung cancer cells

por Pei, X-H, Nakanishi, Y, Takayama, K, Bai, F, Hara, N
Publicado 1999

A new human chromogranin A (CgA) immunoradiometric assay involving monoclonal antibodies raised against the unprocessed central domain (145-245)

por Degorce, F, Goumon, Y, Jacquemart, L, Vidaud, C, Bellanger, L, Pons-Anicet, D, Seguin, P, Metz-Boutigue, M H, Aunis, D
Publicado 1999

Pharmacodynamics of cisplatin in human head and neck cancer: correlation between platinum content, DNA adduct levels and drug sensitivity in vitro and in vivo

por Welters, M J P, Fichtinger-Schepman, A M J, Baan, R A, Jacobs-Bergmans, A J, Kegel, A, van der Vijgh, W J F, Braakhuis, B J M
Publicado 1999

Telomerase activity in melanoma and non-melanoma skin cancer

por Parris, C N, Jezzard, S, Silver, A, MacKie, R, McGregor, J M, Newbold, R F
Publicado 1999

BRCA1 mutations and other sequence variants in a population-based sample of Australian women with breast cancer

por Southey, M C, Tesoriero, A A, Andersen, C R, Jennings, K M, Brown, S M, Dite, G S, Jenkins, M A, Osborne, R H, Maskiell, J A, Porter, L, Giles, G G, McCredie, M R E, Hopper, J L, Venter, D J
Publicado 1999